Dr. Reddy’s Laboratories has launched Doxycycline Capsules, 40 mg, in the U.S. market.
A therapeutic generic equal of Swiss drugmaker Galderma Holdings’ Oracea (doxycycline, USP) Capsules, 40 mg, the product is a tetracycline-class drug. It is indicated for therapy of inflammatory lesions (papules and pustules) related to rosacea in grownup sufferers. The launch by Dr. Reddy’s follows U.S. Food and Drug Administration approval.
